Novartis teams with Qualcomm on $100M digital health fund

Novartis ($NVS) has joined with the venture wing of Qualcomm ($QCOM) to create a $100 million digital health investment fund. The deal gives Novartis access to the most active digital health VC team--Rock Health reports Qualcomm Ventures has struck 21 deals since 2011--and further strengthens the ties between the two companies. News of the VC fund emerged one week after Novartis revealed it is using clinical trial technology from Qualcomm. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

Eric Perakslis' experience with Takeda will help facilitate a new collaboration between the two companies.